16.1% on semaglutide Tirzepatide was superior on all five key secondary endpoints Gastrointestinal discontinuation rate was lower with tirzepatide (2.7%) than semaglutide (5.6%) These findings were consistent across all patient subgroups, regardless of sex, age, baseline BMI, or presence of metabolic comorbidities
Many people allow their tirzepatide to warm slightly before injection to reduce discomfort
Methods: Twenty-eight male Wistar rats were randomly divided into four groups (n=7): normal control, negative control (diclofenac sodium 10 mg/kg body weight [BW]), and two treatment groups receiving turmeric extract (100 mg/kg BW or 200 mg/kg BW) following diclofenac induction
10.1016/j.biotechadv.2009.04.002 2 AhnS
Now that theyre in it, they figured out that once again, the tool, the hammer in your tool belt, can build you or can break you